Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6 USD | +2.56% | -14.00% | +17.42% |
Jun. 10 | Lakeshore Biopharma Co., Ltd Announces Executive Changes | CI |
May. 28 | YS Biopharma Co., Ltd. will Change its Ticker to LSB from YS | CI |
Business Summary
Number of employees: 773
Sales per Business
USD in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceutical Products
100.0
%
| 38 | 100.0 % | 78 | 100.0 % | +106.75% |
Sales per region
USD in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 38 | 100.0 % | 78 | 100.0 % | +106.75% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Hui Shao
CEO | Chief Executive Officer | 55 | 20-12-30 |
Chun Yuan Wu
DFI | Director of Finance/CFO | 46 | 20-12-30 |
Zenaida Mojares
CTO | Chief Tech/Sci/R&D Officer | 65 | 21-12-31 |
Gang Li
SAM | Sales & Marketing | 42 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Viren Mehta
BRD | Director/Board Member | 74 | - |
Hui Shao
CEO | Chief Executive Officer | 55 | 20-12-30 |
Ajit Shetty
CHM | Chairman | 77 | 20-12-31 |
Rachel Yu
BRD | Director/Board Member | 50 | Jan. 06 |
Chun Yuan Wu
DFI | Director of Finance/CFO | 46 | 20-12-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 188,327,959 | 34,976,425 ( 18.57 %) | 0 | 18.57 % |
Company contact information
YS Biopharma Co. Ltd.
Daxing Biomedical Industry Park 38 Yongda Road
102629, Beijing
+
http://www.ysbiopharm.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.42% | 113M | |
+1.86% | 93.91B | |
-1.32% | 38.4B | |
-13.44% | 32.61B | |
+76.30% | 28.2B | |
-13.11% | 15.91B | |
+0.68% | 14.22B | |
-12.06% | 11.54B | |
+185.28% | 10.74B | |
-53.00% | 9.47B |
- Stock Market
- Equities
- LSB Stock
- Company LakeShore Biopharma Co., Ltd